When to increase your Mounjaro, Zepbound or Wegovy dose, and when the label says to wait
The short answer
When to increase your Mounjaro dose: the label says in 2.5 mg steps after at least 4 weeks on the current dose, if additional glycemic control (blood sugar control) is needed. The other labels also set a minimum time first: 4 weeks per step for Wegovy injection, Zepbound, Ozempic and Trulicity, 30 days for the tablets, and one week for Saxenda. Your prescriber decides each increase.
Key takeaways
- Mounjaro: 2.5 mg steps after at least 4 weeks, and only if more blood sugar control is needed.
- Where a label says "at least 4 weeks," that is the earliest a step can come, not a deadline.
- Zepbound 5 mg, 10 mg and 15 mg are all labeled maintenance doses for weight reduction.
- Wegovy injection dose not tolerated? The label says to consider delaying escalation for 4 weeks.
- Zepbound or Mounjaro with the pill: use a non-oral or barrier method for 4 weeks after starting and after each step up.
On this page
- The minimum time at each dose
- “At least” means a floor
- What the labels say about waiting longer
- What the labels say about staying on a lower dose
- What the labels say about stepping down or switching form
- Going above the usual maintenance dose
- A check that is not about going up
- What changes when your dose goes up
- Questions to take to your prescriber
- Frequently asked questions
- Sources
The labels answer “when can I go up?” with a minimum. They answer “do I have to?” much less evenly. This page takes the two questions apart. First, the earliest each label allows an increase. Then what the labels say about going slower, stopping at a lower dose or stepping down.
None of this tells you to change your own dose. An increase is a new prescription, written by your prescriber.
The minimum time at each dose
Four weeks, for the weekly injections.
- Wegovy injection. A fixed timetable of 4-week blocks, reaching 2.4 mg in week 17.
- Zepbound. 2.5 mg for 4 weeks, then 5 mg. After that, 2.5 mg increments “after at least 4 weeks on the current dose.”
- Mounjaro. 2.5 mg increments “after at least 4 weeks on the current dose,” if additional glycemic control is needed.
- Ozempic injection. 0.25 mg for 4 weeks, then 0.5 mg. Increases to 1 mg and then 2 mg come after at least 4 weeks on the dose before, if additional glycemic control is needed.
- Trulicity. An increase to 1.5 mg may come after 4 weeks, with further 1.5 mg increments after at least 4 weeks on the current dosage.
Thirty days, for the tablets. Foundayo requires at least 30 days on each dosage before the next. Wegovy tablets, Ozempic tablets and Rybelsus are scheduled in 30-day blocks.
One week, for Saxenda. The dose goes up each week over the first four weeks, reaching 3 mg from week 5.
The full step lists are on the titration schedules page.
“At least” means a floor
The phrase the labels use most is “at least 4 weeks.” It sets the earliest date for a step. It doesn’t set a latest date.
That matters for the labels that tie increases to a condition:
- Mounjaro, Ozempic and Trulicity increase “if additional glycemic control is needed.” Glycemic control means blood sugar control. If more isn’t needed, the label gives no instruction to go up.
- Zepbound says the dosage “may be increased” beyond 5 mg.
- Foundayo says the dosage “may be increased to the next dosage level” beyond 5.5 mg, “based on treatment response and tolerability.”
Only a few steps are written as plain instructions: Zepbound’s move from 2.5 mg to 5 mg, Ozempic’s from 0.25 mg to 0.5 mg, Foundayo’s first two increases, and the fixed timetables for Wegovy, Saxenda and the first 60 days of the semaglutide tablets. In each of those, the dose you’re leaving is a starting or escalation dose (a step on the way up). The Zepbound label says 2.5 mg “is not approved as a maintenance dosage,” and the Saxenda label says doses below 3 mg are “for titration only” in adults.
What the labels say about waiting longer
Two labels in our records describe a delay directly.
Wegovy injection. If a dose is not tolerated during escalation, the label says to consider delaying dosage escalation for 4 weeks.
Saxenda. If an increased dose is not tolerated, the label says to consider delaying dosage escalation for approximately one additional week.
Both are written as something the prescriber considers. Neither sets a limit on how the delay is used, and neither describes skipping a step afterward.
What the labels say about staying on a lower dose
Zepbound gives the widest choice. The recommended maintenance dosage for weight reduction and long-term maintenance is 5 mg, 10 mg or 15 mg once weekly. If you stop at 5 mg or 10 mg, you’re on a labeled maintenance dose. For obstructive sleep apnea, the label’s maintenance doses are 10 mg or 15 mg. Our dose records describe the 7.5 mg and 12.5 mg strengths as escalation steps, because the label doesn’t name them as maintenance doses.
Wegovy injection names 2.4 mg as the usual recommended maintenance dosage. For weight reduction in adults, the label gives the maintenance dosage as either 1.7 mg or 2.4 mg, with 2.4 mg recommended. Our dose record also notes 1.7 mg as an alternative maintenance dosage for cardiovascular risk reduction and as a step-down option for MASH.
Mounjaro, Ozempic, Trulicity and Rybelsus are built around staying lower when a higher dose isn’t needed, since each increase depends on glycemic control. Trulicity’s 0.75 mg starting dose may be continued. For Rybelsus and Ozempic tablets, the second dose is kept from day 61 unless additional glycemic control is needed.
Foundayo treats 5.5 mg as the first dose where going further is optional.
Saxenda is the strict one. For adults, 3 mg daily is the recommended dosage and lower dosages are for titration only. Our dose record notes that an adult who can’t tolerate 3 mg should discontinue (stop) Saxenda, and that pediatric patients who don’t tolerate 3 mg may have their maintenance dose reduced to 2.4 mg daily.
What the labels say about stepping down or switching form
Beyond the Saxenda pediatric reduction and the Wegovy options above, our records hold one more labeled route. For Wegovy tablets, if the 25 mg once daily maintenance dosage is not tolerated, the label says to consider switching to Wegovy injection 1.7 mg once weekly. That’s a change of form within one brand, described by its own label.
If side effects make your current dose of Zepbound, Mounjaro, Ozempic injection or Trulicity hard to continue, contact your prescriber. They can decide between holding, reducing or stopping.
Going above the usual maintenance dose
One label describes an optional step past its standard maintenance dose. Adults taking Wegovy for weight reduction who tolerate 2.4 mg for at least 4 weeks, and for whom additional weight reduction is clinically indicated, may be increased to a maximum of 7.2 mg once weekly. Every condition is in that sentence: adult, weight reduction, 4 weeks tolerated, clinically indicated. It isn’t a maintenance option for the label’s other uses.
A check that is not about going up
Saxenda’s label includes a review point. It says to evaluate the change in body weight 16 weeks after starting, and to discontinue Saxenda if the patient has not lost at least 4% of baseline body weight (your weight when you started). The label’s reasoning is that clinically meaningful weight loss is then unlikely with continued treatment.
What changes when your dose goes up
Birth control, on tirzepatide. The Zepbound and Mounjaro labels advise people using oral hormonal contraceptives (birth control pills) to switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose escalation. Every step up restarts that 4-week window. For example, say you’re on Mounjaro and take the pill. You’d use the backup for 4 weeks after your first dose. When your dose later goes up, the same 4 weeks starts over from that step.
Price. For some self-pay programs the price changes with the strength, and refill-timing rules can start at higher doses. The cost calculator prices each step, and the 45-day refill rule page explains the Zepbound case.
Your supply. A new strength is a new fill. If your dose goes up partway through a carton, ask your pharmacist what to do with the doses you have left, and use the supply tracker to line up the dates.
Questions to take to your prescriber
- Which approved use is my prescription for, and which maintenance doses does the label name for it?
- Is my next increase a fixed step on the label or an optional one?
- If I’m not tolerating this dose, does the label describe a delay, and would you use it?
- What would make you hold my dose where it is?
The titration schedule tool shows the earliest date for each step from your start date. That’s a useful thing to bring to the conversation. For the overview of all eight medicines, go back to the GLP-1 dosing guide. For what to do after a gap, see the missed dose rules.
Frequently asked questions
When do you increase the Mounjaro dose?
The Mounjaro label says to increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose, if additional glycemic control is needed. At least 4 weeks is the earliest date for a step, not a latest date. Whether to step up at all is up to your prescriber, and an increase is a new prescription.
What dose of Zepbound is most effective?
The Zepbound label names three recommended maintenance doses for weight reduction, 5 mg, 10 mg or 15 mg once weekly, and doesn't single one out. For obstructive sleep apnea it names 10 mg or 15 mg. The 2.5 mg starting dose is not approved as a maintenance dose. Which maintenance dose fits you is for your prescriber to decide.
When do you increase the Wegovy dose?
The injection label gives each escalation dose a 4-week block: 0.25 mg, 0.5 mg, 1 mg and 1.7 mg for 4 weeks each, then 2.4 mg from week 17. If a dose is not tolerated, the label says to consider delaying escalation for 4 weeks. Wegovy tablets step up every 30 days. Your prescriber writes each new strength.
When can you go up on Zepbound?
The label sets two timings. After 4 weeks on the 2.5 mg starting dose, the dose goes up to 5 mg. From there, it may be increased in 2.5 mg steps after at least 4 weeks on the current dose, up to 15 mg. The words are 'may be increased', so steps above 5 mg are your prescriber's decision, not an automatic schedule.
Can I stay on a lower dose of Zepbound?
The label names 5 mg, 10 mg or 15 mg once weekly as recommended maintenance doses for weight reduction, so 5 mg and 10 mg are maintenance doses in their own right. For obstructive sleep apnea the maintenance doses are 10 mg or 15 mg. The 2.5 mg starting dose is not approved as a maintenance dose. Which one you stay on is your prescriber's call.
Can I stay on 1.7 mg of Wegovy instead of 2.4 mg?
For weight reduction in adults, the label says the maintenance dosage is either 1.7 mg or 2.4 mg once weekly, with 2.4 mg recommended. So 1.7 mg is a labeled maintenance option for that use. The label calls 2.4 mg the usual recommended maintenance dosage. Whether 1.7 mg suits you is a question for your prescriber.
Can I increase my dose sooner than 4 weeks?
The labels don't describe it. Each one states a minimum: after 4 weeks, or after at least 4 weeks on the current dose, for the weekly injections, and 30 days for the tablets. The Wegovy label says its escalation is followed to reduce the risk of gastrointestinal adverse reactions (stomach and gut side effects).
Can you go back down a dose if side effects are bad?
A few labels cover it. Wegovy's says to consider delaying the next increase by 4 weeks, and offers 1.7 mg as an alternative maintenance dosage for adult weight reduction. Saxenda's allows pediatric patients who don't tolerate 3 mg to be reduced to 2.4 mg. For Zepbound, Mounjaro, Ozempic or Trulicity, ask your prescriber.
Sources (16)
- 1.Zepbound prescribing information, section 2 (dose increases)
“After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly. The dosage may be increased in 2.5 mg increments, after at least 4 weeks on the current dose [see Dosage and Administration (2.2)].”
- 2.Mounjaro prescribing information, section 2 (dose increases)
“If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose.”
- 3.Wegovy prescribing information, section 2 (7.2 mg)
“For patients who tolerate the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated, the dosage may be increased to a maximum dosage of 7.2 mg subcutaneously once weekly.”
- 4.Wegovy prescribing information, section 2 (tablet maintenance dosage not tolerated)
“If patients do not tolerate the 25 mg once daily maintenance dosage, consider switching to WEGOVY injection 1.7 mg once weekly [see Dosage and Administration (2.5)].”
- 5.Ozempic prescribing information, section 2 (dose increases)
“If additional glycemic control is needed after at least 4 weeks on the: 0.5 mg dosage, the dosage may be increased to 1 mg once weekly.”
- 6.Trulicity prescribing information, section 2 (dose increases)
“After 4 weeks, the dosage may be increased to 1.5 mg once weekly for additional glycemic control. If additional glycemic control is needed, increase the dosage in 1.5 mg increments after at least 4 weeks on the current dosage.”
- 7.Foundayo prescribing information, section 2 (dose increases)
“The dosage may be increased to the next dosage level (9 mg, 14.5 mg, or 17.2 mg once daily) after at least 30 days on the current dosage, based on treatment response and tolerability.”
- 8.Saxenda prescribing information, section 2 (adult dosage)
“For adults, the recommended dosage of SAXENDA is 3 mg daily, lower dosages are for titration only.”
- 9.FDA label (DailyMed): Zepbound prescribing information, section 2.1
“The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage.”
- 10.FDA label (DailyMed): Zepbound prescribing information, section 2.2
“The recommended maintenance dosage is 5 mg, 10 mg, or 15 mg, injected subcutaneously once weekly.”
- 11.FDA label (DailyMed): Zepbound prescribing information, section 8.3
“Use of ZEPBOUND may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying. This delay is largest after the first dose and diminishes over time. Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method, or add a barrier method of contraception for 4 weeks after initiation with ZEPBOUND and for 4 weeks after each dose escalation [see Drug Interactions (7.2) and Clinical Pharmacology (12.2, 12.3)].”
- 12.FDA label (DailyMed): Mounjaro prescribing information, section 8.3
“Use of MOUNJARO may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying. This delay is largest after the first dose and diminishes over time. Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method or add a barrier method of contraception for 4 weeks after initiation and for 4 weeks after each dose escalation with MOUNJARO [see Drug Interactions (7.2) and Clinical Pharmacology (12.2, 12.3)].”
- 13.FDA label (DailyMed): Foundayo prescribing information, section 2.1
“The starting dosage is 0.8 mg orally once daily. After at least 30 days on the 0.8 mg dosage, increase the dosage to 2.5 mg once daily.”
- 14.FDA label (DailyMed): Foundayo prescribing information, section 2.1
“The maximum dosage of FOUNDAYO is 17.2 mg once daily.”
- 15.FDA label (DailyMed): Trulicity prescribing information, section 2.1
“The maximum recommended dosage is 4.5 mg injected subcutaneously once weekly.”
- 16.FDA label (DailyMed): Saxenda prescribing information, section 2.2
“Evaluate the change in body weight 16 weeks after initiating SAXENDA and discontinue SAXENDA if the patient has not lost at least 4% of baseline body weight, since it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment.”
Related pages
- GLP-1 dosing chart: how the eight medicines start, step up and settle
- Zepbound dose schedule and every other GLP-1 titration schedule, week by week
- Tirzepatide dosage chart and semaglutide dosing: every strength of every GLP-1
- Missed dose of Ozempic, Zepbound or Wegovy: the label rule for every GLP-1
- What is Wegovy? Uses, doses, pill and pen, and cost
- What is Zepbound? Uses, cost, doses and side effects
